Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Status: Enrolling
Updated:  12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Status: Enrolling
Updated: 12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Status: Enrolling
Updated:  12/31/1969
Texas Pul & Crit Care Conslt
mi
from
Fort Worth, TX
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Status: Enrolling
Updated: 12/31/1969
Texas Pul & Crit Care Conslt
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants and Children 6 to 24 Months of Age
Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-attenuated Respiratory Syncytial Virus Vaccine, LID cp ΔM2-2, Lot RSV#009B, Delivered as Nose Drops to RSV-Seronegative Infants and Children 6 to 24 Months of Age
Status: Enrolling
Updated:  12/31/1969
Center for Immunization Research - Johns Hopkins Bloomberg School of Public Health
mi
from
Baltimore, MD
Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants and Children 6 to 24 Months of Age
Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-attenuated Respiratory Syncytial Virus Vaccine, LID cp ΔM2-2, Lot RSV#009B, Delivered as Nose Drops to RSV-Seronegative Infants and Children 6 to 24 Months of Age
Status: Enrolling
Updated: 12/31/1969
Center for Immunization Research - Johns Hopkins Bloomberg School of Public Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants and Children 6 to 24 Months of Age
Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-attenuated Respiratory Syncytial Virus Vaccine, LID cp ΔM2-2, Lot RSV#009B, Delivered as Nose Drops to RSV-Seronegative Infants and Children 6 to 24 Months of Age
Status: Enrolling
Updated:  12/31/1969
Center for Immunization Research East, Johns Hopkins Bayview Medical Center Campus
mi
from
Baltimore, MD
Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants and Children 6 to 24 Months of Age
Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-attenuated Respiratory Syncytial Virus Vaccine, LID cp ΔM2-2, Lot RSV#009B, Delivered as Nose Drops to RSV-Seronegative Infants and Children 6 to 24 Months of Age
Status: Enrolling
Updated: 12/31/1969
Center for Immunization Research East, Johns Hopkins Bayview Medical Center Campus
mi
from
Baltimore, MD
Click here to add this to my saved trials
Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants and Children 6 to 24 Months of Age
Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-attenuated Respiratory Syncytial Virus Vaccine, LID cp ΔM2-2, Lot RSV#009B, Delivered as Nose Drops to RSV-Seronegative Infants and Children 6 to 24 Months of Age
Status: Enrolling
Updated:  12/31/1969
Center for Immunization Research South
mi
from
Laurel, MD
Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants and Children 6 to 24 Months of Age
Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-attenuated Respiratory Syncytial Virus Vaccine, LID cp ΔM2-2, Lot RSV#009B, Delivered as Nose Drops to RSV-Seronegative Infants and Children 6 to 24 Months of Age
Status: Enrolling
Updated: 12/31/1969
Center for Immunization Research South
mi
from
Laurel, MD
Click here to add this to my saved trials
Initiation of CPAP for Newly Diagnosed OSA in Hospitalized Heart Failure Patients
Initiation of CPAP for Newly Diagnosed OSA in Hospitalized Heart Failure Patients: A Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
West Virginia University
mi
from
Morgantown, WV
Initiation of CPAP for Newly Diagnosed OSA in Hospitalized Heart Failure Patients
Initiation of CPAP for Newly Diagnosed OSA in Hospitalized Heart Failure Patients: A Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
West Virginia University
mi
from
Morgantown, WV
Click here to add this to my saved trials
Assessment of Lung Movement With Computed Tomography (CT)
Assessment of Lung Movement With CT in Healthy Subjects and Patients With ILD
Status: Enrolling
Updated:  12/31/1969
University Of Missouri-Columbia
mi
from
Columbia, MO
Assessment of Lung Movement With Computed Tomography (CT)
Assessment of Lung Movement With CT in Healthy Subjects and Patients With ILD
Status: Enrolling
Updated: 12/31/1969
University Of Missouri-Columbia
mi
from
Columbia, MO
Click here to add this to my saved trials
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated:  12/31/1969
Paragould Pediatrics
mi
from
Paragould, AR
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated: 12/31/1969
Paragould Pediatrics
mi
from
Paragould, AR
Click here to add this to my saved trials
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated:  12/31/1969
Eureka Pediatrics
mi
from
Eureka, CA
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated: 12/31/1969
Eureka Pediatrics
mi
from
Eureka, CA
Click here to add this to my saved trials
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated:  12/31/1969
Pediatric Partners of the Southwest
mi
from
Durango, CO
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated: 12/31/1969
Pediatric Partners of the Southwest
mi
from
Durango, CO
Click here to add this to my saved trials
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated:  12/31/1969
Pediatric Medicine of Wallingford
mi
from
Wallingford, CT
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated: 12/31/1969
Pediatric Medicine of Wallingford
mi
from
Wallingford, CT
Click here to add this to my saved trials
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated:  12/31/1969
Advance Preventive Care
mi
from
Bradenton, FL
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated: 12/31/1969
Advance Preventive Care
mi
from
Bradenton, FL
Click here to add this to my saved trials
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated:  12/31/1969
A to Z Pediatric & Youth Healthcare
mi
from
Addison, IL
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated: 12/31/1969
A to Z Pediatric & Youth Healthcare
mi
from
Addison, IL
Click here to add this to my saved trials
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated:  12/31/1969
All Star Pediatrics
mi
from
Countryside, IL
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated: 12/31/1969
All Star Pediatrics
mi
from
Countryside, IL
Click here to add this to my saved trials
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated:  12/31/1969
Deerfield
mi
from
Deerfield, IL
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated: 12/31/1969
Deerfield
mi
from
Deerfield, IL
Click here to add this to my saved trials
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated:  12/31/1969
Evanston (Central)
mi
from
Evanston, IL
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated: 12/31/1969
Evanston (Central)
mi
from
Evanston, IL
Click here to add this to my saved trials
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated:  12/31/1969
Evanston (Davis)
mi
from
Evanston, IL
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated: 12/31/1969
Evanston (Davis)
mi
from
Evanston, IL
Click here to add this to my saved trials
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated:  12/31/1969
Glenview
mi
from
Glenview, IL
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated: 12/31/1969
Glenview
mi
from
Glenview, IL
Click here to add this to my saved trials
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated:  12/31/1969
Investigator Site - Gurnee
mi
from
Gurnee, IL
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated: 12/31/1969
Investigator Site - Gurnee
mi
from
Gurnee, IL
Click here to add this to my saved trials
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated:  12/31/1969
Lincolnwood
mi
from
Lincolnwood, IL
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated: 12/31/1969
Lincolnwood
mi
from
Lincolnwood, IL
Click here to add this to my saved trials
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated:  12/31/1969
Old Orchard
mi
from
Skokie, IL
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated: 12/31/1969
Old Orchard
mi
from
Skokie, IL
Click here to add this to my saved trials
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated:  12/31/1969
Vernon Hills
mi
from
Vernon Hills, IL
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated: 12/31/1969
Vernon Hills
mi
from
Vernon Hills, IL
Click here to add this to my saved trials
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated:  12/31/1969
Plaza Del Lago
mi
from
Wilmette, IL
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated: 12/31/1969
Plaza Del Lago
mi
from
Wilmette, IL
Click here to add this to my saved trials
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated:  12/31/1969
East End
mi
from
East Hampton, NY
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated: 12/31/1969
East End
mi
from
East Hampton, NY
Click here to add this to my saved trials
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated:  12/31/1969
Hampton Pediatrics
mi
from
Southampton, NY
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated: 12/31/1969
Hampton Pediatrics
mi
from
Southampton, NY
Click here to add this to my saved trials
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated:  12/31/1969
Plateau Pediatrics
mi
from
Crossville, TN
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated: 12/31/1969
Plateau Pediatrics
mi
from
Crossville, TN
Click here to add this to my saved trials
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated:  12/31/1969
Cornerstone Pediatrics
mi
from
Seguin, TX
Dialogue Around Respiratory Illness Treatment
Dialogue Around Respiratory Illness Treatment
Status: Enrolling
Updated: 12/31/1969
Cornerstone Pediatrics
mi
from
Seguin, TX
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
Pacific Treatment and Research Center
mi
from
La Jolla, CA
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
Pacific Treatment and Research Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
Matrix Institute on Addictions
mi
from
Los Angeles, CA
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
Matrix Institute on Addictions
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
Pharmacology Research Institute
mi
from
Newport Beach, CA
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
Pharmacology Research Institute
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
Meridien Research
mi
from
Lakeland, FL
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
Meridien Research
mi
from
Lakeland, FL
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
Behavioral Clinical Research, Inc.
mi
from
North Miami, FL
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
Behavioral Clinical Research, Inc.
mi
from
North Miami, FL
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
Boston University School of Medicine
mi
from
Boston, MA
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
Altea Research Institute
mi
from
Las Vegas, NV
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
Altea Research Institute
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
Neuro-Behavioral Clinical Research, Inc.
mi
from
Canton, OH
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
Neuro-Behavioral Clinical Research, Inc.
mi
from
Canton, OH
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
CODA, Inc.
mi
from
Portland, OR
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
CODA, Inc.
mi
from
Portland, OR
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
George Washington University
mi
from
Washington,
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
George Washington University
mi
from
Washington,
Click here to add this to my saved trials
High-Flow Oxygen for Dyspnea in Hospitalized Cancer Patients
High-Flow Oxygen for Dyspnea in Hospitalized Cancer Patients
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
High-Flow Oxygen for Dyspnea in Hospitalized Cancer Patients
High-Flow Oxygen for Dyspnea in Hospitalized Cancer Patients
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
RSV Investigational Vaccine in RSV-seropositive Infants Aged 12 to 23 Months
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Topeka, KA
RSV Investigational Vaccine in RSV-seropositive Infants Aged 12 to 23 Months
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Topeka, KA
Click here to add this to my saved trials
RSV Investigational Vaccine in RSV-seropositive Infants Aged 12 to 23 Months
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Syracuse, NY
RSV Investigational Vaccine in RSV-seropositive Infants Aged 12 to 23 Months
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Syracuse, NY
Click here to add this to my saved trials
RSV Investigational Vaccine in RSV-seropositive Infants Aged 12 to 23 Months
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Frederick, MD
RSV Investigational Vaccine in RSV-seropositive Infants Aged 12 to 23 Months
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Frederick, MD
Click here to add this to my saved trials
RSV Investigational Vaccine in RSV-seropositive Infants Aged 12 to 23 Months
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Sioux Falls, SD
RSV Investigational Vaccine in RSV-seropositive Infants Aged 12 to 23 Months
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
RSV Investigational Vaccine in RSV-seropositive Infants Aged 12 to 23 Months
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Anaheim, CA
RSV Investigational Vaccine in RSV-seropositive Infants Aged 12 to 23 Months
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
RSV Investigational Vaccine in RSV-seropositive Infants Aged 12 to 23 Months
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Aurora, CO
RSV Investigational Vaccine in RSV-seropositive Infants Aged 12 to 23 Months
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Aurora, CO
Click here to add this to my saved trials
RSV Investigational Vaccine in RSV-seropositive Infants Aged 12 to 23 Months
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Halifax,
RSV Investigational Vaccine in RSV-seropositive Infants Aged 12 to 23 Months
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Halifax,
Click here to add this to my saved trials